Form 4: Elevance Health Director Ramiro G Peru Sells Shares

Sentiment:

SEC Form 4 Filing


Director Ramiro G Peru sold 753 shares of Elevance Health, Inc. (ELV) at a price of $531.52 on August 5, 2024, according to a Form 4 filing.

Summary

  • On August 5, 2024, Ramiro G Peru, a director of Elevance Health, Inc. (ELV), sold 753 shares of common stock at a price of $531.52 per share.
  • The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 6, 2024.
  • Following the transaction, Peru directly owns 8,744 shares of Elevance Health common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, reporting a sale of shares by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Insider transactions are routinely monitored by investors as they can provide signals, though not always definitive, about a company's prospects. A sale by a director may or may not be indicative of the company's future performance.

Stakeholder Impact

  • The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a pre-arranged trading plan mitigates this concern.

Key Dates

DateDescription
05/06/2024Date of adoption of Rule 10b5-1 trading plan
08/05/2024Date of transaction (sale of shares)
08/06/2024Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.